Musculoskeletal disorders in acromegaly compromise upper and lower limb activity. Corresponding changes can be better assessed by a functional capacity test incorporating multitasking, such as the Glittre Activities of Daily Living Test (GA-T).
OBJECTIVES:
To evaluate functional capacity in adults with acromegaly using the GA-T and to correlate functional capacity with hand function and health-related quality of life.
METHODS:
The GA-T was applied to 36 patients with acromegaly and an equal number of healthy individuals. Additionally, participants completed the Acromegaly Quality of Life (AcroQoL) questionnaire and underwent a chronic pain assessment using a map of the human body, a hand function evaluation using the Cochin Hand Functional Scale (CHFS), and a handgrip strength test.
RESULTS:
Relative to the comparison group, patients with acromegaly required more time to perform the GA-T, showed worse hand function, and reported that squatting to accomplish shelving tasks was the major difficulty. GA-T time was correlated with the AcroQoL global score, handgrip strength, and the CHFS (0.487, 0.002; 0.369, 0.026; 0.538, 0.0007, respectively).
CONCLUSIONS:
Patients with acromegaly exhibited a reduced functional capacity as assessed by the GA-T. Additionally, an association was identified between the total GA-T time and both hand function and quality of life.
LavrentakiAPaluzziAWassJAKaravitakiN. Epidemiology of acromegaly: review of population studies. Pituitary.2017; 20(1): 4-9.
2.
BollerslevJHeckAOlarescuNC. Management of endocrine disease: individualized management of acromegaly. Eur J Endocrinol.2019; 181(2): R57-71.
3.
GadelhaMRKasukiLLimDSTFleseriuM. Systemic complications of acromegaly and the impact of the current treatment landscape: an update. Endocr Rev.2018; 40(1): 268-332.
4.
LimaTRLKasukiLGadelhaMRLopesAJ. The effectiveness of a therapist-oriented home rehabilitation program for a patient with acromegaly: a case study. J Bodyw Mov Ther.2019; 23(3): 634-42.
5.
MazziottiGLaniaACanalisE. Management of endocrine disease: bone disorders associated with acromegaly: mechanisms and treatment. Eur J Endocrinol.2019; 181(2): R45-56.
6.
BiermaszNRPereiraAMSmitJWARomijnJARoelfsemaF. Morbidity after long-term remission for acromegaly: persisting joint-related complaints cause reduced quality of life. J Clin Endocrinol Metab.2005; 90(5): 2731-9.
7.
ClaessenKMRamautarSRPereiraAMRomijnJAKroonHMKloppenburgM, et al. Increased clinical symptoms of acromegalic arthropathy in patients with long-term disease control: a prospective follow-up study. Pituitary.2014; 17(1): 44-52.
8.
MelmedSCasanuevaFFKlibanskiABronsteinMDChansonPLambertsSW, et al. A consensus on the diagnosis and treatment of acromegaly complications. Pituitary.2013; 16(3): 294-302.
9.
FattiLMCangianoBVitaleGPersaniLMantovaniGSalaE, et al. Arthropathy in acromegaly: a questionnaire-based estimation of motor disability and its relation with quality of life and work productivity. Pituitary.2019; 22(5): 552-60.
10.
BiermaszNRvan ’t KloosterRWassenaarMJMalmSHClaessenKMNelissenRG, et al. Automated image analysis of hand radiographs reveals widened joint spaces in patients with long-term control of acromegaly: relation to disease activity and symptoms. Eur J Endocrinol.2012; 166(3): 407-13.
11.
FüchtbauerLOlssonDSBengtssonBÅNorrmanLLSunnerhagenKSJohannssonG. Muscle strength in patients with acromegaly at diagnosis and during long-term follow-up. Eur J Endocrinol.2017; 177(2): 217-26.
12.
WalchanEMGuimarãesFSSoaresMSKasukiLGadelhaMRLopesAJ. Parameters of knee isokinetic dynamometry in individuals with acromegaly: association with growth hormone levels and general fatigue. Isokinet Exerc Sci.2016; 24(4): 331-40.
13.
HomemTSGuimarãesFSSoaresMSKasukiLGadelhaMRLopesAJ. Balance control and peripheral muscle function in aging: a comparison between individuals with acromegaly and healthy subjects. J Aging Phys Act.2017; 25(2): 218-27.
14.
HoevenarenIAWagenmakersMARoerinkSHNetea-MaierRTUlrichDJMaalTJ. Three-dimensional soft tissue analysis of the hand: a novel method to investigate effects of acromegaly. Eur J Plast Surg.2016; 39(6): 429-34.
15.
Guedes da SilvaDPGuimarãesFSDiasCMGuimarães SdeAKasukiLGadelhaMR, et al. On the functional capacity and quality of life of patients with acromegaly: are they candidates for rehabilitation programs? J Phys Ther Sci.2013; 25(11): 1497-501.
16.
WebbSMBadiaX. Quality of life in acromegaly. Neuroendocrinology.2016; 103(1): 106-11.
17.
LopesAJGuedes da SilvaDPFerreira AdeSKasukiLGadelhaMRGuimarãesFS. What is the effect of peripheral muscle fatigue, pulmonary function, and body composition on functional exercise capacity in acromegalic patients? J Phys Ther Sci.2015; 27(3): 719-24.
18.
SkumlienSHagelundTBjørtuftORygMS. A field test of functional status as performance of activities of daily living in COPD patients. Respir Med.2006; 100(2): 316-23.
19.
NonatoCPAzevedoBLPAOliveiraJGMGardelaDGde SouzaDCNLopesAJ. The glittre activities of daily living test in women with scleroderma and its relation to hand function and physical capacity. Clin Biomech.2020; 73: 71-77.
20.
Andrade JuniorABFerreiraASAssisACBNascimentoLPASRibeiroCFPapathanasiouJV, et al. Cardiac autonomic control in women with rheumatoid arthritis during the glittre activities of daily living test. Asian J Sports Med.2020; 11(2): e101400.
21.
GulartAAMunariABTressoldiCDos SantosKKarlohMMayerAF. Glittre-ADL multiple tasks induce similar dynamic hyperinflation with different metabolic and ventilatory demands in patients with COPD. J Cardiopulm Rehabil Prev.2017; 37(6): 450-53.
22.
Fernandes-AndradeAABrittoRRSoaresDCMVellosoMPereiraDAG. Evaluation of the Glittre-ADL test as an instrument for classifying functional capacity of individuals with cardiovascular diseases. Braz J Phys Ther.2017; 21(5): 321-8.
23.
ArikanHYatarİCalik-KutukcuEAribasZSaglamMVardar-YagliN, et al. A comparison of respiratory and peripheral muscle strength, functional exercise capacity, activities of daily living and physical fitness in patients with cystic fibrosis and healthy subjects. Res Dev Disabil.2015; 45-46: 147-56.
24.
KatznelsonLLawsER JrMelmedSMolitchMEMuradMHUtzA, et al. Acromegaly: an endocrine society clinical practice guideline. J Clin Endocrinol Metab.2014; 99(11): 3933-51.
25.
BadiaXWebbSMPrietoLLaraN. Acromegaly quality of life questionnaire (AcroQoL). Health Qual Life Outcomes.2004; 2: 13.
26.
MargolisRBTaitRCKrauseSJ. A rating system for use with patient pain drawings. Pain.1986; 24(1): 57-65.
27.
MargolisRBChibnallJTTaitRC. Test-retest reliability of the pain drawing instrument. Pain.1988; 33(1): 49-51.
28.
BrowerLMPooleJL. Reliability and validity of the duruoz hand index in persons with systemic sclerosis (scleroderma). Arthritis. Rheum.2004; 51(5): 805-9.
29.
ChiariASardimCNatourJ. Translation, cultural adaptation and reproducibility of the cochin hand functional scale questionnaire for Brazil. Clinics.2011; 66(5): 731-6.
30.
CrosbyCAWehbeMAMawrB. Hand strength: normative values. J Hand Surg Am.1994; 19(4): 665-70.
31.
DechmanGSchererSA. Outcome measures in cardiopulmonary physical therapy: focus on the Glittre ADL-test for people with chronic obstructive pulmonary disease. Cardiopulm Phys Ther J.2008; 19(4): 115-8.
32.
ReisCMDKarlohMFonsecaFRBiscaroRRMMazoGZMayerAF. Functional capacity measurement: reference equations for the glittre activities of daily living test. J Bras Pneumol.2018; 44(5): 370-7.
33.
KarlohMKarstenMPissaiaFVde AraujoCLMayerAF. Physiological responses to the Glittre-ADL test in patients with chronic obstructive pulmonary disease. J Rehabil Med.2014; 46(1): 88-94.
34.
GulartAAMunariABQueirozAPCaniKCMatteDLMayerAF. Does the COPD assessment test reflect functional status in patients with COPD? Chron Respir Dis.2017; 14(1): 37-44.
35.
KocksJWAsijeeGTsiligianniIKerstjensHvan der MolenT. Functional status measurement in COPD: a review of available methods and their feasibility in primary care. Prim Care Respir J.2011; 20(3): 269-75.
36.
CorreaKSKarlohMMartinsLQdos SantosKMayerAF. Can the Glittre ADL test differentiate the functional capacity of COPD patients from that of healthy subjects? Rev Bras Fisioter.2011; 15(6): 467-73.
37.
KillingerZKužmaMSteranc̆ákováLPayerJ. Osteoarticular changes in acromegaly. Int J Endocrinol.2012; 2012: 839282.
38.
SlaterLVHartJM. Muscle activation patterns during different squat techniques. J Strength Cond Res.2017; 31(3): 667-76.
39.
KitamuraTKidoAIshidaYKobayashiYTsukamotoSTanakaY. Muscle activity pattern with a shifted center of pressure during the squat exercise. J Sports Sci Med.2019; 18(2): 248-52.
40.
KillingerZPayerJLazúrováIImrichRHomérováZKužmaM, et al. Arthropathy in acromegaly. Rheum Dis Clin North Am.2010; 36(4): 713-20.
41.
LevisAWHarelDKwakkenbosLCarrierMEMouthonLPoiraudeauS, et al. Using optimal test assembly methods for shortening patient-reported outcome measures: development and validation of the cochin hand function scale-6: a scleroderma patient-centered intervention network cohort study. Arthritis Rheum.2016; 68(11): 1704-13.
42.
PooleJL. Measures of adult hand function. Arthritis Rheum.2003; 49(5S): S59-66.
43.
SinghMAF. Exercise and aging. Clin Geriatr Med.2004; 20(2): 201-21.
44.
WebbSMPrietoLBadiaXAlbaredaMCataláMGaztambideS, et al. Acromegaly quality of life questionnaire (ACROQOL) a new health-related quality of life questionnaire for patients with acromegaly: development and psychometric properties. Clin Endocrinol.2002; 57(2): 251-8.
45.
MillerADollHDavidJWassJ. Impact of musculoskeletal disease on quality of life in long-standing acromegaly. Eur J Endocrinol.2008; 158(5): 587-93.
46.
MonteiroFPonceDASilvaHCarrilhoAFPittaF. Validity and reproducibility of the Glittre ADL-test in obese and post-bariatric surgery patients. Obes Surg.2017; 27(1): 110-4.
47.
JoséADal CorsoS. Inpatient rehabilitation improves functional capacity, peripheral muscle strength and quality of life in patients with community-acquired pneumonia: a randomised trial. J Physiother.2016; 62(2): 96-102.
48.
HughesPDPolkeyMIHarrusMLCoatsAJMoxhamJGreenM. Diaphragm strength in chronic heart failure. Am J Respir Crit Care Med.1999; 160(2): 529-34.
